Iterum Therapeutics plc (ITRM) Revenue History
Annual and quarterly revenue from 2016 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ITRM Revenue Growth
ITRM Revenue Analysis (2016–2024)
As of May 8, 2026, Iterum Therapeutics plc (ITRM) generated trailing twelve-month (TTM) revenue of $390,000. The most recent quarter (Q3 2025) recorded $390,000 in revenue.
Looking at the longer-term picture, ITRM's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $869,000 in 2018.
When compared to Healthcare sector peers including NKTR (-43.9% YoY), SPRO (-64.7% YoY), and VNDA (+8.2% YoY). Compare ITRM vs NKTR →
ITRM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ITRMCurrent | $390,000 | - | - | - | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 SPRO | $48M | -64.7% | +21.5% | -152.9% | |
 VNDA | $216M | +8.2% | -2.7% | -70.0% |
ITRM Historical Revenue Data (2016–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-254,000 | - | $-18,696,000 | - |
| 2023 | $0 | - | $-1,750,000 | - | $-47,468,000 | - |
| 2022 | $0 | - | $-1,800,000 | - | $-30,383,000 | - |
| 2021 | $0 | - | $-2,104,000 | - | $-24,537,000 | - |
| 2020 | $0 | -100.0% | $-161,000 | - | $-32,126,000 | - |
| 2019 | $37K | -95.7% | $37K | 100.0% | $-102,021,000 | -275732.4% |
| 2018 | $869K | +71.1% | $869K | 100.0% | $-76,559,000 | -8810.0% |
| 2017 | $508K | - | $508K | 100.0% | $-29,455,000 | -5798.2% |
| 2016 | $0 | - | $0 | - | $-13,359,000 | - |
See ITRM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ITRM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ITRM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonITRM — Frequently Asked Questions
Quick answers to the most common questions about buying ITRM stock.
Is ITRM's revenue growth accelerating or slowing?
ITRM TTM revenue: $390000.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ITRM's long-term revenue growth rate?
Iterum Therapeutics plc's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ITRM's revenue distributed by segment?
ITRM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2024 are available for download. Segment mix reveals concentration and diversification trends.